Bio-Techne, Oxford Nanopore Expand Partnership for Genetics Portfolio Development
The extended agreement through 2032 broadens commercial rights beyond the recently launched carrier screening kit to accelerate diagnostic innovation.
The extended agreement through 2032 broadens commercial rights beyond the recently launched carrier screening kit to accelerate diagnostic innovation.
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Labcorp Whole Health Solutions is a new initiative offering specialized test panels and over 1,000 biomarkers.
Source BioScience has acquired Cambridge Clinical Laboratories to expand its clinical diagnostics capabilities and enhance testing services.
Read MoreNeoGenomics has acquired Pathline, LLC to strengthen its presence in the Northeast U.S. and accelerate growth in oncology testing services.
Read MoreNeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
Read MoreCo-Diagnostics successfully won the complete dismissal of a securities class action lawsuit on March 4, 2025.
Read MoreBaylor Genetics celebrates its 10-year anniversary, highlighting its leadership in precision diagnostics and innovative genetic testing.
Read MoreSummary:BD (Becton, Dickinson and Company) announced its plan to separate its Biosciences and...
Read MoreHealthTrackRx opened a new campus at the UPS Healthcare Labport in Louisville, enabling next-morning infection diagnostics nationwide.
Read MoreWildcat DX, LLC has acquired Navis Clinical Laboratories, Inc., enhancing its portfolio of diagnostic lab testing services.
Read MoreTracamyl has acquired the Hektros brand, previously owned by Tratter Engineering, to expand its range and expertise in life sciences.
Read MoreZeiss and Mindpeak have joined forces to create an integrated multiplex immunofluorescence solution for pathologists.
Read MoreSummary: Sysmex’s CAP accreditation and ISO certification, reinforces its commitment to delivering...
Read MoreOncoHost’s CLIA-certified proteomics lab received CAP accreditation, emphasizing its commitment to precision-focused diagnostics for cancer.
Read MoreQIAGEN is relocating its QIAstat-Dx operations to a new facility in Barcelona to strengthen its syndromic testing capabilities.
Read MoreTrinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MoreThe CLIA-certified lab launched a pharmacogenetic assay to empower tailored treatments for psychiatric, neurological, and related conditions.
Read More